Location of FDA's public workshop on bioequivalence of solid oral dosage forms has been changed to the J. W. Marriott, 1331 Pennsylvania Ave., NW, Washington, D.C. Meeting will be held Sept. 29-Oct, 1, 9 am to 5 pm.
You may also be interested in...
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.
The regulatory tools are for use in medical device development.